Reconstruction of upper extremity and thoracic central veins using dedicated venous stents: Implantation of 75 stents in 46 patients

Abstract

Dedicated self-expanding bare-metal venous stents, including Abre (Medtronic; Dublin, Ireland), Venovo (Becton, Dickinson, and Company; Franklin Lakes, NJ), Vici (Boston Scientific; Marlborough, MA), and Zilver Vena (Cook Medical; Bloomington, IN), are approved for the treatment of iliofemoral venous occlusive disease.1–4 This report describes the use of these venous stents in the upper extremity and thoracic central veins. Institutional review board approval was obtained for preparation of this report.